CervoMed Inc. Operating Cash Flow
CervoMed Inc. (CRVO) reported Operating Cash Flow of -$14.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- CervoMed Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$6.92M.
- CervoMed Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$8.02M.
- CervoMed Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.58M.
- CervoMed Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.47M.
- CervoMed Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$23.45M.
- CervoMed Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$16.53M.
- CervoMed Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$7.45M.
- CervoMed Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$2.57M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$14.94M 10-Q · filed 2026-08-07 | -$21.51M derived: sum of 3 quarters · filed 2026-08-07 | -$27.98M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$8.02M 10-Q · filed 2026-05-15 | -$14.59M derived: sum of 2 quarters · filed 2026-05-15 | -$21.06M derived: sum of 3 quarters · filed 2026-05-15 | -$27.57M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -$6.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$13.04M derived: sum of 2 quarters · filed 2026-03-13 | -$19.56M derived: sum of 3 quarters · filed 2026-08-07 | -$23.45M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | -$6.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$12.98M derived: sum of 2 quarters · filed 2026-08-07 | -$16.87M 10-Q · filed 2025-11-07 | -$24.93M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$6.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$10.41M 10-Q · filed 2026-08-07 | -$18.46M derived: sum of 3 quarters · filed 2026-08-07 | -$23.31M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$3.89M 10-Q · filed 2026-05-15 | -$11.95M derived: sum of 2 quarters · filed 2026-05-15 | -$16.80M derived: sum of 3 quarters · filed 2026-05-15 | -$19.00M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$8.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$12.91M derived: sum of 2 quarters · filed 2026-03-13 | -$15.11M derived: sum of 3 quarters · filed 2026-03-13 | -$16.53M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | -$4.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$7.06M derived: sum of 2 quarters · filed 2025-11-07 | -$8.48M 10-Q · filed 2025-11-07 | -$11.02M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$3.63M 10-Q · filed 2025-08-08 | -$6.16M derived: sum of 3 quarters · filed 2025-08-08 | -$7.63M derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | -$1.42M 10-Q · filed 2025-05-12 | -$3.96M derived: sum of 2 quarters · filed 2025-05-12 | -$5.43M derived: sum of 3 quarters · filed 2025-05-12 | -$7.39M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$4.01M derived: sum of 2 quarters · filed 2025-03-17 | -$5.97M derived: sum of 3 quarters · filed 2025-03-17 | -$7.45M 10-K · filed 2025-03-17 | ||||
| 2023-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$3.43M derived: sum of 2 quarters · filed 2024-11-12 | -$4.91M 10-Q · filed 2024-11-12 | -$5.60M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$3.44M 10-Q · filed 2024-08-09 | -$7.61M 10-Q · filed 2023-08-08 | -$4.14M derived: sum of 3 quarters · filed 2024-08-09 | $2.72M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | -$1.48M 10-Q · filed 2024-05-14 | -$4.97M 10-Q · filed 2023-05-15 | -$2.17M derived: sum of 2 quarters · filed 2024-05-14 | $4.68M derived: sum of 3 quarters · filed 2024-05-14 | $675.11K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$692.53K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $6.16M derived: sum of 2 quarters · filed 2024-03-29 | $2.16M derived: sum of 3 quarters · filed 2024-03-29 | -$2.57M 10-K · filed 2024-03-29 | -$14.97M 10-K · filed 2023-03-24 | |||
| 2022-09-30 | $6.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.85M derived: sum of 2 quarters · filed 2023-11-13 | -$1.88M 10-Q · filed 2023-11-13 | -$11.50M 10-Q · filed 2022-11-14 | -$4.91M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$4.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$8.74M 10-Q · filed 2023-08-08 | -$11.76M derived: sum of 3 quarters · filed 2023-08-08 | -$14.74M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | -$4.73M 10-Q · filed 2023-05-15 | -$7.76M derived: sum of 2 quarters · filed 2023-05-15 | -$10.73M derived: sum of 3 quarters · filed 2023-05-15 | -$14.06M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -$6.00M derived: sum of 2 quarters · filed 2023-03-24 | -$9.33M derived: sum of 3 quarters · filed 2023-03-24 | -$14.50M 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | -$2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$6.30M derived: sum of 2 quarters · filed 2022-11-14 | -$11.48M 10-Q · filed 2022-11-14 | -$14.87M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$3.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$8.50M 10-Q · filed 2022-08-12 | -$11.90M derived: sum of 3 quarters · filed 2022-08-12 | -$15.41M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$5.18M 10-Q · filed 2022-05-12 | -$8.57M derived: sum of 2 quarters · filed 2022-05-12 | -$12.08M derived: sum of 3 quarters · filed 2022-05-12 | -$15.22M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$6.90M derived: sum of 2 quarters · filed 2022-03-18 | -$10.05M derived: sum of 3 quarters · filed 2022-03-18 | -$13.55M 10-K · filed 2022-03-18 | ||||
| 2020-09-30 | -$3.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$6.65M derived: sum of 2 quarters · filed 2021-11-10 | -$10.16M 10-Q · filed 2021-11-10 | -$12.60M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$3.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$6.65M 10-Q · filed 2021-08-11 | -$9.09M derived: sum of 3 quarters · filed 2021-08-11 | -$11.24M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | -$3.50M 10-Q · filed 2021-05-07 | -$5.94M derived: sum of 2 quarters · filed 2021-05-07 | -$8.10M derived: sum of 3 quarters · filed 2021-05-07 | -$10.71M derived: sum of 4 quarters · filed 2021-05-07 | ||||
| 2019-12-31 | -$2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$4.59M derived: sum of 2 quarters · filed 2021-03-17 | -$7.20M derived: sum of 3 quarters · filed 2021-03-17 | -$9.86M 10-K · filed 2021-03-17 | ||||
| 2019-09-30 | -$2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$4.76M derived: sum of 2 quarters · filed 2020-11-12 | -$7.42M 10-Q · filed 2020-11-12 | -$10.45M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | -$2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$5.27M 10-Q · filed 2020-08-07 | -$8.29M derived: sum of 3 quarters · filed 2020-08-07 | -$10.21M derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2019-03-31 | -$2.66M 10-Q · filed 2020-05-11 | -$5.68M derived: sum of 2 quarters · filed 2020-05-11 | -$7.60M derived: sum of 3 quarters · filed 2020-05-11 | -$10.14M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | -$3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$4.94M derived: sum of 2 quarters · filed 2020-03-17 | -$7.48M derived: sum of 3 quarters · filed 2020-03-17 | -$10.77M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | -$1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$4.46M derived: sum of 2 quarters · filed 2019-11-08 | -$7.75M 10-Q · filed 2019-11-08 | -$10.03M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | -$2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$5.83M 10-Q · filed 2019-08-08 | -$8.11M derived: sum of 3 quarters · filed 2019-08-08 | -$12.00M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$3.29M 10-Q · filed 2019-05-09 | -$5.57M derived: sum of 2 quarters · filed 2019-05-09 | -$9.46M derived: sum of 3 quarters · filed 2019-05-09 | -$12.21M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | -$6.17M derived: sum of 2 quarters · filed 2019-03-19 | -$8.92M derived: sum of 3 quarters · filed 2019-03-19 | -$12.33M 10-K · filed 2019-03-19 | ||||
| 2017-09-30 | -$3.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$6.63M derived: sum of 2 quarters · filed 2018-11-13 | -$10.05M 10-Q · filed 2018-11-13 | -$11.46M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$6.16M 10-Q · filed 2018-08-10 | -$7.58M derived: sum of 3 quarters · filed 2018-08-10 | -$9.44M derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | -$3.42M 10-Q · filed 2018-05-10 | -$4.83M derived: sum of 2 quarters · filed 2018-05-10 | -$6.69M derived: sum of 3 quarters · filed 2018-05-10 | -$9.55M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$3.28M derived: sum of 2 quarters · filed 2018-04-02 | -$6.14M derived: sum of 3 quarters · filed 2018-04-02 | -$10.77M 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | -$1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$4.72M derived: sum of 2 quarters · filed 2017-11-13 | -$9.35M 10-Q · filed 2017-11-13 | -$11.62M derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | -$2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$7.49M 10-Q · filed 2017-08-14 | -$9.76M derived: sum of 3 quarters · filed 2017-08-14 | -$10.74M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | -$4.63M 10-Q · filed 2017-05-15 | -$6.90M derived: sum of 2 quarters · filed 2017-05-15 | -$7.88M derived: sum of 3 quarters · filed 2017-05-15 | -$8.88M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | -$2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$3.25M derived: sum of 2 quarters · filed 2017-03-31 | -$4.25M derived: sum of 3 quarters · filed 2017-03-31 | -$5.19M 10-K · filed 2017-03-31 | -$9.60M 10-K · filed 2016-03-25 | |||
| 2015-09-30 | -$981.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$1.98M derived: sum of 2 quarters · filed 2016-11-14 | -$2.92M 10-Q · filed 2016-11-14 | -$7.03M 10-Q · filed 2015-11-12 | -$4.85M derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | -$998.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$1.94M 10-Q · filed 2016-08-15 | -$5.13M 10-Q · filed 2015-08-12 | -$3.87M derived: sum of 3 quarters · filed 2016-08-15 | -$5.85M derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | -$938.78K 10-Q · filed 2016-05-16 | -$2.65M 10-Q · filed 2015-05-11 | -$2.87M derived: sum of 2 quarters · filed 2016-05-16 | -$4.85M derived: sum of 3 quarters · filed 2016-05-16 | -$9.54M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$3.91M derived: sum of 2 quarters · filed 2016-03-25 | -$8.60M derived: sum of 3 quarters · filed 2016-03-25 | -$9.03M 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$6.67M derived: sum of 2 quarters · filed 2015-11-12 | -$7.10M 10-Q · filed 2015-11-12 | -$7.10M derived: sum of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | -$4.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$5.12M 10-Q · filed 2015-08-12 | -$5.12M derived: sum of 3 quarters · filed 2015-08-12 | -$5.45M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2014-03-31 | -$432.89K 10-Q · filed 2015-05-11 | -$433.53K derived: sum of 2 quarters · filed 2015-05-11 | -$766.53K derived: sum of 3 quarters · filed 2015-05-11 | -$1.22M derived: sum of 4 quarters · filed 2015-05-11 | ||||
| 2013-12-31 | -$633.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | -$333.64K derived: sum of 2 quarters · filed 2015-04-03 | -$783.97K derived: sum of 3 quarters · filed 2015-04-03 | -$1.18M 10-K · filed 2015-04-03 | ||||
| 2013-09-30 | -$333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$783.34K derived: sum of 2 quarters · filed 2014-11-12 | -$1.18M 10-Q · filed 2014-11-12 | -$2.68M derived: sum of 4 quarters · filed 2014-11-12 | ||||
| 2013-06-30 | -$450.34K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-14 | -$850.99K 10-Q · filed 2014-08-14 | -$2.35M derived: sum of 3 quarters · filed 2014-08-14 | -$2.91M derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | -$400.66K 10-Q/A · filed 2013-05-20 | -$1.90M derived: sum of 2 quarters · filed 2014-04-23 | -$2.46M derived: sum of 3 quarters · filed 2014-04-23 | -$2.86M derived: sum of 4 quarters · filed 2014-04-23 | ||||
| 2012-12-31 | -$1.50M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | -$2.06M derived: sum of 2 quarters · filed 2014-04-23 | -$2.46M derived: sum of 3 quarters · filed 2014-04-23 | -$4.31M 10-K/A · filed 2014-04-23 | ||||
| 2012-09-30 | -$559.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | -$966.60K derived: sum of 2 quarters · filed 2013-11-19 | -$2.81M 10-Q · filed 2013-11-19 | -$6.04M derived: sum of 4 quarters · filed 2013-11-19 | ||||
| 2012-06-30 | -$407.26K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-14 | -$2.25M 10-Q · filed 2013-08-14 | -$5.48M derived: sum of 3 quarters · filed 2013-08-14 | -$9.93M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | -$1.85M 10-Q/A · filed 2013-05-20 | -$5.07M derived: sum of 2 quarters · filed 2013-05-20 | -$9.52M derived: sum of 3 quarters · filed 2013-05-20 | |||||
| 2011-12-31 | -$3.22M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | -$7.68M derived: sum of 2 quarters · filed 2013-04-24 | -$12.02M 10-K/A · filed 2013-04-24 | |||||
| 2011-09-30 | -$4.45M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | -$8.80M 10-Q · filed 2012-11-19 | ||||||
| 2011-06-30 | -$4.35M 10-Q/A · filed 2012-09-07 | |||||||
| 2010-12-31 | -$390.99K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-21 | -$1.13M derived: sum of 2 quarters · filed 2012-05-21 | -$1.98M 10-K · filed 2012-05-21 | |||||
| 2010-09-30 | -$741.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | -$1.59M 10-Q · filed 2011-11-21 | ||||||
| 2010-06-30 | -$848.22K 10-Q · filed 2011-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |